Streetbeat News

Analyst Ratings

CI

CVS

LLY

NVO

UNH

Novo Nordisk's weight loss drug, semaglutide, has shown a 20% reduction in major adverse cardiovascular events in a large scale study. This has positive implications for Eli Lilly's similar weight loss drug, Mounjaro. However, the prospect of insurers needing to cover these expensive drugs has led to a fall in stocks of health insurers like UnitedHealth Group, Cigna Group, and CVS Health Corp. Eli Lilly has reported strong earnings and raised its FY23 guidance. The company also has a promising Alzheimer's drug in the pipeline.

Portfolio Pulse from The Arora Report

August 09, 2023 | 3:10 pm

TDG

RBC Capital analyst Ken Herbert maintains an Outperform rating on TransDigm Gr (NYSE:TDG) and raises the price target from $920 to $975.

Portfolio Pulse from richadhand@benzinga.com

August 09, 2023 | 3:08 pm

ZVIA

Morgan Stanley analyst Dara Mohsenian has maintained an Equal-Weight rating on Zevia (NYSE:ZVIA) and lowered the price target from $3.5 to $3.25.

Portfolio Pulse from Benzinga Newsdesk

August 09, 2023 | 3:07 pm

SQSP

RBC Capital analyst Brad Erickson maintains a 'Sector Perform' rating on Squarespace (NYSE:SQSP) and raises the price target from $30 to $32.

Portfolio Pulse from richadhand@benzinga.com

August 09, 2023 | 3:06 pm

WMG

Morgan Stanley analyst Benjamin Swinburne has maintained an Overweight rating on Warner Music Group (NASDAQ:WMG) and raised the price target from $34 to $38.

Portfolio Pulse from Benzinga Newsdesk

August 09, 2023 | 3:06 pm

SEE

RBC Capital analyst Arun Viswanathan has maintained an 'Outperform' rating on Sealed Air (NYSE:SEE) but lowered the price target from $47 to $45.

Portfolio Pulse from richadhand@benzinga.com

August 09, 2023 | 3:06 pm

SGMO

RBC Capital analyst Luca Issi has maintained an 'Outperform' rating on Sangamo Therapeutics (NASDAQ:SGMO), but lowered the price target from $8 to $6.

Portfolio Pulse from richadhand@benzinga.com

August 09, 2023 | 3:05 pm

KNF

DA Davidson analyst Brent Thielman maintains a Buy rating on Knife River Holding (NYSE:KNF) and raises the price target from $54 to $58.

Portfolio Pulse from jenniferd'souza@benzinga.com

August 09, 2023 | 3:04 pm

RIVN

RBC Capital analyst Tom Narayan has maintained a 'Sector Perform' rating on Rivian Automotive (NASDAQ:RIVN) and raised the price target from $14 to $15.

Portfolio Pulse from richadhand@benzinga.com

August 09, 2023 | 3:04 pm

QDEL

RBC Capital analyst Conor McNamara has reiterated an Outperform rating on QuidelOrtho (NASDAQ:QDEL) and maintained a price target of $136.

Portfolio Pulse from richadhand@benzinga.com

August 09, 2023 | 3:03 pm